Molecular imaging of cell-mediated cancer immunotherapy

被引:34
|
作者
Lucignani, Giovanni
Ottobrini, Luisa
Martelli, Cristina
Rescigno, Maria
Clerici, Mario
机构
[1] Univ Milan, Inst Radiol Sci, I-20142 Milan, Italy
[2] European Inst Oncol, Unit Mol Imaging, Div Radiat Therapy, I-20141 Milan, Italy
[3] European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy
[4] Univ Milan, Osped L Sacco, Padigl LITA, I-20154 Milan, Italy
关键词
D O I
10.1016/j.tibtech.2006.07.003
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
New strategies based on the activation of a patient's immune response are being sought to complement present conventional exogenous cancer therapies. Elucidating the trafficking pathways of immune cells in vivo, together with their migratory properties in relation to their differentiation and activation status, is useful for understanding how the immune system interacts with cancer. Methods based on tissue sampling to monitor immune responses are inadequate for repeatedly characterizing the responses of the immune system in different organs. A solution to this problem might come from molecular and cellular imaging - a branch of biomedical sciences that combines biotechnology and imaging methods to characterize, in vivo, the molecular and cellular processes involved in normal and pathologic states. The general concepts of noninvasive imaging of targeted cells as well as the technology and probes applied to cell-mediated cancer immunotherapy imaging are outlined in this review.
引用
收藏
页码:410 / 418
页数:9
相关论文
共 50 条
  • [21] Induced pluripotency as a potential path towards iNKT cell-mediated cancer immunotherapy
    Hiroshi Watarai
    Daisuke Yamada
    Shin-ichiro Fujii
    Masaru Taniguchi
    Haruhiko Koseki
    International Journal of Hematology, 2012, 95 : 624 - 631
  • [22] NK cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy
    Wang, Wei
    Erbe, Amy K.
    Hank, Jacquelyn A.
    Morris, Zachary S.
    Sondel, Paul M.
    FRONTIERS IN IMMUNOLOGY, 2015, 6
  • [23] NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy
    Malmberg, Karl-Johan
    Bryceson, Yenan T.
    Carlsten, Mattias
    Andersson, Sandra
    Bjorklund, Andreas
    Bjorkstrom, Niklas K.
    Baumann, Bettina C.
    Fauriat, Cyril
    Alici, Evren
    Dilber, M. Sirac
    Ljunggren, Hans-Gustaf
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2008, 57 (10) : 1541 - 1552
  • [24] T cell-mediated cancer immunotherapy through OX40 agonism
    Huseni, M.
    Du, C.
    Zhu, J.
    Pacheco-Sanchez, P.
    Moskalenko, M.
    Chiu, H.
    Dalpozzo, K.
    Totpal, K.
    Damico-Beyer, L.
    Kim, J.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 45 - 45
  • [25] Mitochondrial apoptosis: facilitator of NK cell-mediated immunotherapy
    Ullrich, Evelyn
    Vogler, Meike
    von Metzler, Ivana
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)
  • [26] Mitochondrial apoptosis: facilitator of NK cell-mediated immunotherapy
    Evelyn Ullrich
    Meike Vogler
    Ivana von Metzler
    Signal Transduction and Targeted Therapy, 7
  • [27] Molecular mechanisms in cell-mediated cytotoxicity
    Moretta, A
    CELL, 1997, 90 (01) : 13 - 18
  • [28] Harnessing IL-15 signaling to potentiate NK cell-mediated cancer immunotherapy
    Ma, Shoubao
    Caligiuri, Michael A.
    Yu, Jianhua
    TRENDS IN IMMUNOLOGY, 2022, 43 (10) : 833 - 847
  • [29] Molecular basis of T cell-mediated recognition of pancreatic cancer cells
    Ito, M
    Shichijo, S
    Tsuda, N
    Ochi, M
    Harashima, N
    Saito, N
    Itoh, K
    CANCER RESEARCH, 2001, 61 (05) : 2038 - 2046
  • [30] Cell membrane-encapsulated magnetic nanoparticles for enhancing natural killer cell-mediated cancer immunotherapy
    Wu, Dan
    Shou, Xin
    Zhang, Yalan
    Li, Zihan
    Wu, Guohua
    Wu, Di
    Wu, Jianguo
    Shi, Shengyu
    Wang, Shuqi
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2021, 32